{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:11:16Z","timestamp":1783923076314,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mast cell activation syndrome (MCAS) is characterized by pronounced heterogeneity, fluctuating severity, delayed post-perturbation crashes analogous to those documented in post-exertional malaise, and highly variable clinical trajectories that are poorly explained by mediator-centric diagnostic approaches. Patients with similar symptom profiles or laboratory findings often follow divergent courses, while resting biomarkers frequently fail to correlate with functional capacity or prognosis. Beyond serving as markers of activation, mast-cell mediators influence neural, vascular, epithelial, immune, and autonomic systems, providing a biologically plausible mechanism through which local perturbations may propagate into multisystem instability. Building on a pressure\u2013reserve framework of energetic constraint, this paper proposes a stability-state classification framework for interpreting system behavior and identifying operating regimes. Four operational stability classifications are proposed\u2014recovery-capable, plateau, slow drift, and crash-prone\u2014based on the relationship between energetic reserve and reactive pressure, modulated by the degree of multisystem synchronization. Recovery-capable, plateau, and slow-drift classifications are conceptual regions along a continuous fragility axis, whereas crash-prone behavior is proposed as a threshold-crossing regime characterized by impaired recovery dynamics, hysteresis, and increased susceptibility to instability. Three complementary stability axes are introduced: energetic reserve, dominant pressure domain (dominant ingress), and synchronization. Together, these axes generate characteristic classification signatures that remain observable despite overlapping mediator profiles and fluctuating baseline values. This framework reframes MCAS as a disorder of state-dependent instability rather than mediator burden alone, provides a structured means to interpret heterogeneity, stratify patients prognostically, and track trajectory over time, and offers a foundation for longitudinal monitoring and future validation studies grounded in system dynamics rather than isolated biomarkers.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1865449","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:21Z","timestamp":1783920921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Energetic stability states in mast cell activation syndrome: operationalizing reserve, pressure, and threshold collapse"],"prefix":"10.3389","volume":"17","author":[{"given":"Richard","family":"Tellier","sequence":"first","affiliation":[{"name":"Independent Researcher","place":["Land O\u2019 Lakes, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1515\/dx-2026-0016","article-title":"Progress in mast cell activation syndrome: the global consensus-2 diagnostic criteria at six years","author":"Afrin","year":"2026","journal-title":"Diagnosis (Berl)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaip.2025.10.046","article-title":"Diagnosis and management of patients with mast cell activation syndromes: status 2026","volume":"14","author":"Akin","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-024-00924-w","article-title":"Mast cell activation syndrome and gut dysfunction: diagnosis and management","volume":"26","author":"Hamilton","year":"2024","journal-title":"Curr Gastroenterol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","article-title":"Mast cell activation syndrome: proposed diagnostic criteria","volume":"126","author":"Akin","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jaip.2019.08.022","article-title":"Mast cell activation syndrome: tools for diagnosis and differential diagnosis","volume":"8","author":"Weiler","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.iac.2018.04.011","article-title":"Mast cell mediators of significance in clinical practice in mastocytosis","volume":"38","author":"Butterfield","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"B9","first-page":"155","article-title":"Presentation, diagnosis, and management of mast cell activation syndrome","volume-title":"Mast Cells: Phenotypic Features, Biological Functions and Role in Immunity","author":"Afrin","year":"2013"},{"key":"B10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1196\/annals.1366.025","article-title":"The critical role of mast cells in allergy and inflammation","volume":"1088","author":"Theoharides","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1300\/J092v14n02_07","article-title":"Diminished cardiopulmonary capacity during post-exertional malaise","volume":"14","author":"VanNess","year":"2007","journal-title":"J Chronic Fatigue Syndr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbi.2017.02.009","article-title":"Neural consequences of post-exertion malaise in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"62","author":"Cook","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2796.2009.02160.x","article-title":"Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome","volume":"267","author":"Jones","year":"2010","journal-title":"J Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02545-y","article-title":"A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms","volume":"396","author":"Molderings","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B16","article-title":"Allostasis: a new paradigm to explain arousal pathology","volume-title":"Handbook of Life Stress, Cognition and Health","author":"Sterling","year":"1988"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.es.04.110173.000245","article-title":"Resilience and stability of ecological systems","volume":"4","author":"Holling","year":"1973","journal-title":"Annu Rev Ecol Syst"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1994.266.4.H1643","article-title":"Physiological time-series analysis: what does regularity quantify","volume":"266","author":"Pincus","year":"1994","journal-title":"Am J Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801153380307","article-title":"Protective and damaging effects of stress mediators","volume":"338","author":"McEwen","year":"1998","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccx.0000139369.65817.b6","article-title":"Nonlinear dynamics, complex systems, and the pathobiology of critical illness","volume":"10","author":"Buchman","year":"2004","journal-title":"Curr Opin Crit Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"097603","DOI":"10.1063\/1.4915529","article-title":"Dynamical disease: challenges for nonlinear dynamics and medicine","volume":"25","author":"Glass","year":"2015","journal-title":"Chaos"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature08227","article-title":"Early-warning signals for critical transitions","volume":"461","author":"Scheffer","year":"2009","journal-title":"Nature"},{"key":"B23","volume-title":"Advanced Methods and Tools for ECG Data Analysis","author":"Clifford","year":"2006"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0014","article-title":"The neuroendocrinology of chronic fatigue syndrome","volume":"24","author":"Cleare","year":"2003","journal-title":"Endocr Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00266-4","article-title":"What is physiologic complexity and how does it change with aging and disease","volume":"23","author":"Goldberger","year":"2002","journal-title":"Neurobiol Aging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","article-title":"Mitochondrial energetics and therapeutics","volume":"5","author":"Wallace","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1474-9728.2003.00079.x","article-title":"Mitochondrial membrane potential and aging","volume":"3","author":"Nicholls","year":"2004","journal-title":"Aging Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00258","article-title":"An overview of heart rate variability metrics and norms","volume":"5","author":"Shaffer","year":"2017","journal-title":"Front Public Health"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(00)00338-4","article-title":"A model of neurovisceral integration in emotion regulation and dysregulation","volume":"61","author":"Thayer","year":"2000","journal-title":"J Affect Disord"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/20924","article-title":"Multifractality in human heartbeat dynamics","volume":"399","author":"Ivanov","year":"1999","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.05.025","article-title":"Mast cell activation syndrome: current understanding and research needs","volume":"154","author":"Castells","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.07.002","article-title":"Mast cell activation disease: an underappreciated cause of neurologic and psychiatric symptoms and diseases","volume":"50","author":"Afrin","year":"2015","journal-title":"Brain Behav Immun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.10.032","article-title":"Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation","volume":"132","author":"Theoharides","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13080920","article-title":"Oxidative stress and mitochondria are involved in anaphylaxis and mast cell degranulation: a systematic review","volume":"13","author":"Piotin","year":"2024","journal-title":"Antioxid (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1037\/h0040957","article-title":"Construct validity in psychological tests","volume":"52","author":"Cronbach","year":"1955","journal-title":"Psychol Bull"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1207\/s15366359mea0204_1","article-title":"A manifesto on psychology as idiographic science","volume":"2","author":"Molenaar","year":"2004","journal-title":"Measurement (Mahwah NJ)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1037\/a0017912","article-title":"Issues in intraindividual variability: individual differences in equilibria and dynamics","volume":"24","author":"Boker","year":"2009","journal-title":"Psychol Aging"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent","year":"2010","journal-title":"Trials"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2: subgroup analysis in randomised controlled trials\u2014importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002049","article-title":"Why most clinical research is not useful","volume":"13","author":"Ioannidis","year":"2016","journal-title":"PloS Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.144501","article-title":"Postural tachycardia syndrome (POTS)","volume":"127","author":"Raj","year":"2013","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12852","article-title":"Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management","volume":"285","author":"Fedorowski","year":"2019","journal-title":"J Intern Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-023-01307-w","article-title":"Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities","volume":"23","author":"Blitshteyn","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2012\/15\/es205","article-title":"Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise","volume":"15","author":"Nijs","year":"2012","journal-title":"Pain Physician"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865449\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:35:23Z","timestamp":1783920923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865449\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2026.1865449"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1865449","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"article-number":"1865449"}}